Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype

Clinical and Experimental Immunology

Volumn 121, Issue 3, 2000, Pages 491-498

  Godot, V ^a   Harraga, S ^a   Beurton, I ^a   Tiberghien, P ^a,b   Sarciron, E ^a,c   Gottstein, B ^a,d   Vuitton, D A ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b Blood Transfusion Centre of Franche Comté   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alveolar echinococcosis; Cellular immunity; IL 10; IL 5; Interferon gamma; Tumour necrosis factor

Indexed keywords

GAMMA INTERFERON; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 5; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIGENS, HELMINTH; CASE-CONTROL STUDIES; CYTOKINES; ECHINOCOCCOSIS; ECHINOCOCCUS; HAPLOTYPES; HLA ANTIGENS; HLA-B8 ANTIGEN; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033864189     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01309.x     Document Type: Article

References (32)

1. Cellular immune response in Echinococcus multilocularis infection in humans. (1) Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis
2. Echinococcosis of the liver
3. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis
4. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis
5. Characterization of T-cell immune response of Echinococcus multilocularis-infected C57BL/6J mice
6. Spontaneous death of Echinococcus multilocularis: Cases diagnosed serologically (by EM2 ELISA) and clinical significance
7. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions
8. HLA and alveolar echinococcosis
9. Immunological and morphological studies on the proliferation of in vivo cultivated Echinococcus multilocularis metacestode
10. Studies on Echinococcosis XV. Secondary multilocular echinococcosis by intrahepatic inoculation
11. Cellular immunity in experimental Echinococcus multilocularis infection. I. Sequential and comparative study of specific in vivo delayed-type hypersensitivity against Echinococcus multilocularis antigens in resistant and sensitive mice
12. Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice
13. Echinococcus multilocularis: Relationship between susceptibility/resistance and liver fibrogenesis in experimental mice
14. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection
15. Common West African HLA antigens are associated with protection from severe malaria
16. Association between HLA-DR13 and susceptibility to alveolar echinococcosis
17. Soluble interleukin-2 receptor defect in vitro in HLA-B8, DR3 positive subjects
18. Lymphocyte abnormality associated with HLA-B8 in healthy young adults
19. T-cell activation in HLA-B8, DR3-positive individuals - Early antigen expression defect in vitro
20. Antibodies against Echinococcus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis
21. Biological properties of interleukin 10
22. Clinical development of interleukin 10
23. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
24. Treatment with recombinant human tumor necrosis factor alpha protects rats against the lethality, hypotension and hyperthermia of Gram negative sepsis
25. The involvement of tumor necrosis factor in immunity to Salmonella infection
26. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis
27. Tumor necrosis factor α and β inhibit virus replication and synergize with interferons
28. The physiopathology of tumor necrosis factor
29. Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-alpha
30. Cellular localisations of interleukin-1β, interleukin-6 and tumor necrosis factor-α mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis
31. Secondary alveolar echinococcosis in lymphotoxin-α and tumor necrosis factor-α deficient mice: Exacerbation of Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic granuloma